Paramount Insurance PLC. (DSE:PARAMOUNT)

Verve Therapeutics Cash Flow Statement

Financials in millions BDT. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	81.11	90.57	70.49	76.03	123.07	182.29
Depreciation & Amortization	5.71	5.7	5.15	5.62	4.98	4.2
Other Amortization	0.29	0.29	-	-	-	-
Change in Accounts Receivable	15.06	0.79	-5.28	14.42	-24.3	-5.29
Change in Insurance Reserves / Liabilities	12.21	50.72	5.88	53.07	-0.51	-1.47
Change in Other Net Operating Assets	2.53	13.98	-9.14	-19.07	65.06	9.11
Other Operating Activities	-38.62	-43.81	-4.49	-1.62	2.3	-95.85
Operating Cash Flow	93.36	118.24	62.62	128.45	170.6	92.99
Operating Cash Flow Growth	25.74%	88.83%	-51.25%	-24.70%	83.46%	449.02%
Capital Expenditures	-38.32	-40.57	-2.77	-155.29	-319.55	-7.28
Sale of Property, Plant & Equipment	0.05	2.04	-	3.03	-	1.02
Investment in Securities	-74.64	-72.42	-10.09	13.84	118.57	11.99
Other Investing Activities	66.62	52.88	139.01	18.06	31.18	30.94
Investing Cash Flow	-46.3	-58.07	126.15	-120.35	-169.8	36.67
Common Dividends Paid	-81.33	-40.66	-40.66	-40.66	-	-6.64
Other Financing Activities	1.9	0.52	0.16	0.71	0.29	-
Financing Cash Flow	-79.43	-40.14	-40.51	-39.96	0.29	-6.64
Miscellaneous Cash Flow Adjustments	0	0	-	-	-	-
Net Cash Flow	-32.37	20.02	148.25	-31.85	1.08	123.01
Free Cash Flow	55.04	77.67	59.84	-26.83	-148.95	85.71
Free Cash Flow Growth	15.13%	29.79%	-	-	-	-
Free Cash Flow Margin	14.46%	17.53%	17.10%	-7.86%	-38.94%	21.50%
Free Cash Flow Per Share	1.35	1.91	1.47	-0.66	-3.66	2.11
Cash Income Tax Paid	24.17	24.78	30.12	38.99	54.66	18.64
Levered Free Cash Flow	266.39	98.72	181.23	-130	-148.11	203.5
Unlevered Free Cash Flow	266.39	98.72	181.23	-130	-148.11	203.5

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.